Quetiapine and novel PDE10A inhibitors potentiate the anti-BuChE activity of donepezil-Reference-Cited by-同舟云学术

Quetiapine and novel PDE10A inhibitors potentiate the anti-BuChE activity of donepezil

Published:2020-01-01 Issue:1 Volume:35 Page:1743-1750
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Sikora Joanna¹,Podsiedlik Maria²,Pietras Tadeusz³,Kosmalski Marcin³,Matłoka Mikołaj⁴,Moszczyński-Petkowski Rafał⁴,Wieczorek Maciej⁴,Markowicz-Piasecka Magdalena¹

Affiliation:

1. Laboratory of Bioanalysis, Department of Pharmaceutical Chemistry, Drug Analysis and Radiopharmacy, Medical University of Lodz, Lodz, Poland

2. Department of Pharmaceutical Chemistry, Drug Analysis and Radiopharmacy, Medical University of Lodz, Lodz, Poland

3. Department of Clinical Pharmacology, Medical University of Lodz, Lodz, Poland

4. Research and Development Department, Celon Pharma S.A, Łomianki, Poland

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2020.1818739

Reference47 articles.

1. History and progress of hypotheses and clinical trials for Alzheimer’s disease

2. Alzheimer’s disease hypothesis and related therapies

3. A bibliometric review of drug repurposing

4. Drug repositioning and repurposing: terminology and definitions in literature

5. Drug repurposing from an academic perspective

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and validation of oxidative stress and immune-related hub genes in Alzheimer’s disease through bioinformatics analysis;Scientific Reports;2023-01-12

2. The Influence of Selected Antipsychotic Drugs on Biochemical Aspects of Alzheimer’s Disease;International Journal of Molecular Sciences;2022-04-21

3. Structure-based discovery and bio-evaluation of a cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one as a phosphodiesterase 10A inhibitor;RSC Advances;2022